StockData
Vyome Holdings, Inc logo

Vyome Holdings, Inc (HIND) stock

HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.54+0.01 (+0.98%)

Close on Nov 17, 2026Market cap $10.84MP/E –Yield –

Vyome r&d expenses

Research and development expenses are spending on new products and technology.

Vyome's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.59M, up 422.2% year over year. For fiscal 2025 it was $588.26K, up 106.1% from the year before. Over ten years it grew -26.6% a year on average. The highest annual figure on record is $12.98M in fiscal 2015.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$588.26K+106.1%
FY2024Dec 31, 2024$285.39K-87.7%
FY2023Dec 31, 2023$2.32M-8.8%
FY2022Dec 31, 2022$2.54M+7.1%
FY2021Dec 31, 2021$2.37M-32.3%
FY2020Dec 31, 2020$3.50M-49.3%
FY2019Dec 31, 2019$6.89M-35.6%
FY2018Dec 31, 2018$10.70M+0.5%
FY2017Dec 31, 2017$10.65M+7.9%
FY2016Dec 31, 2016$9.87M-23.9%
FY2015Dec 31, 2015$12.98M+125.0%
FY2014Dec 31, 2014$5.77M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$506.72K+532.9%
Q1 FY2026Mar 31, 2026$666.41K+638.3%
Q4 FY2025Dec 31, 2025$378.25K+460.1%
Q3 FY2025Sep 30, 2025$39.68K-40.6%
Q2 FY2025Jun 30, 2025$80.06K-79.9%
Q1 FY2025Mar 31, 2025$90.27K-81.3%
Q4 FY2024Dec 31, 2024$67.53K-90.9%
Q3 FY2024Sep 30, 2024$66.82K-87.7%
Q2 FY2024Jun 30, 2024$399.00K-31.3%
Q1 FY2024Mar 31, 2024$484.00K+6.8%
Q4 FY2023Dec 31, 2023$739.00K+60.0%
Q3 FY2023Sep 30, 2023$542.00K-7.0%
Q2 FY2023Jun 30, 2023$581.00K-22.2%
Q1 FY2023Mar 31, 2023$453.00K-39.2%
Q4 FY2022Dec 31, 2022$462.00K+71.1%
Q3 FY2022Sep 30, 2022$583.00K-59.1%
Q2 FY2022Jun 30, 2022$747.00K+625.2%
Q1 FY2022Mar 31, 2022$745.00K+30.5%
Q4 FY2021Dec 31, 2021$270.00K-69.3%
Q3 FY2021Sep 30, 2021$1.43M+65.9%
Q2 FY2021Jun 30, 2021$103.00K-77.8%
Q1 FY2021Mar 31, 2021$571.00K-54.6%
Q4 FY2020Dec 31, 2020$879.00K-41.1%
Q3 FY2020Sep 30, 2020$859.00K-26.8%
Q2 FY2020Jun 30, 2020$465.00K-74.0%
Q1 FY2020Mar 31, 2020$1.26M-48.5%
Q4 FY2019Dec 31, 2019$1.49M-36.2%
Q3 FY2019Sep 30, 2019$1.17M-50.4%
Q2 FY2019Jun 30, 2019$1.79M-46.7%
Q1 FY2019Mar 31, 2019$2.44M-7.6%
Q4 FY2018Dec 31, 2018$2.34M-13.1%
Q3 FY2018Sep 30, 2018$2.37M-15.4%
Q2 FY2018Jun 30, 2018$3.35M+21.4%
Q1 FY2018Mar 31, 2018$2.64M+10.0%
Q4 FY2017Dec 31, 2017$2.69M+3.2%
Q3 FY2017Sep 30, 2017$2.80M+29.0%
Q2 FY2017Jun 30, 2017$2.76M–
Q1 FY2017Mar 31, 2017$2.40M–
Q4 FY2016Dec 31, 2016$2.61M–
Q3 FY2016Sep 30, 2016$2.17M–

More Vyome figures

See a number that looks wrong?